13 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
SideEffects #Table #DecisionAid ... #Orals #DM2 #Diabetes ... Endocrinology #Pharmacology
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... overview #management #comparison
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Choice -Diabetes ... interest to the patient ... #Type2 #DM2 #PatientInfo ... #DecisionAid #Medications ... Reduction #Costs #Pharmacology
Adverse Effects of Antipsychotic Medications - Comparison Table

First Generation: chlopromazine, haloperidol, fluphenazine 
Second Generation: aripirazole, asenapine,
Medications - Comparison ... SideEffects #Adverse #Psychiatry ... #Pharmacology # ... Profiles #Comparison ... #Table #DecisionAid
Antidepressant Medications Decision Aid
 - The choice of depression medications in primary care is difficult as
#PrimaryCare #Psychiatry ... #DecisionAid #SSRIs ... Antidepressants #Comparison ... SNRIs #Selection #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Type 2 Inpatient ... #Mellitus #DM2 ... #pharmacology # ... comparison #table
Side Effects of Atypical and Typical Antipsychotics - Comparison Table
Atypical antipsychotics: Risperidone, Quetiapine, Olanzapine, Amisulpride, Ziprasidone
Antipsychotics - Comparison ... development of diabetes ... #Table #Psychiatry ... #Pharmacology # ... DecisionAid
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... which causes the patient ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... ml/min per 1.73 m2 ... professionals and the patient ... evidence-based pharmacologic ... #Diabetes #CKD #
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
If you see a patient ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology